139 related articles for article (PubMed ID: 20041959)
1. Controversies regarding the prophylactic management of adults with severe haemophilia A.
Valentino LA
Haemophilia; 2009 Dec; 15 Suppl 2():5-18, quiz 19-22. PubMed ID: 20041959
[No Abstract] [Full Text] [Related]
2. Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A.
Bidlingmaier C; Kurnik K; Escuriola-Ettingshausen C; Jager R; Klamroth R; Male C; Marosi A; Nemes L; von Stackelberg A; Kreuz W
Haemophilia; 2011 Sep; 17(5):e837-40. PubMed ID: 21649797
[No Abstract] [Full Text] [Related]
3. Our experience in Sweden with prophylaxis on haemophilia.
Nilsson IM; Blombäck M; Ahlberg A
Bibl Haematol; 1970; 34():111-24. PubMed ID: 5436339
[No Abstract] [Full Text] [Related]
4. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
Ahnström J; Berntorp E; Lindvall K; Björkman S
Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
[TBL] [Abstract][Full Text] [Related]
5. Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A.
van Helden PM; Kaijen PH; Mauser-Bunschoten EP; Fischer K; van den Berg HM; Voorberg J
Haemophilia; 2010 Nov; 16(6):892-901. PubMed ID: 20491952
[TBL] [Abstract][Full Text] [Related]
6. Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia.
Thornburg CD; Pipe SW
Haemophilia; 2006 Mar; 12(2):198-9. PubMed ID: 16476098
[No Abstract] [Full Text] [Related]
7. Allergenic vaccines administration and inhibitor development in haemophilia.
Bermejo N; Martín Aguilera C; Carnicero F; Bergua J
Haemophilia; 2012 Sep; 18(5):e392-3. PubMed ID: 22672147
[No Abstract] [Full Text] [Related]
8. International workshop on immune tolerance induction: consensus recommendations.
DiMichele DM; Hoots WK; Pipe SW; Rivard GE; Santagostino E
Haemophilia; 2007 Jul; 13 Suppl 1():1-22. PubMed ID: 17593277
[TBL] [Abstract][Full Text] [Related]
9. Management of bleeding disorders in children.
Berntorp E; Halimeh S; Gringeri A; Mathias M; Escuriola C; Pérez R
Haemophilia; 2012 May; 18 Suppl 2():15-23. PubMed ID: 22530575
[TBL] [Abstract][Full Text] [Related]
10. Experience with a third generation recombinant factor VIII concentrate (Advate) for immune tolerance induction in patients with haemophilia A.
Valentino LA; Recht M; Dipaola J; Shapiro AD; Pipe SW; Ewing N; Urgo J; Bullock T; Simmons M; Deguzman C
Haemophilia; 2009 May; 15(3):718-26. PubMed ID: 19298383
[TBL] [Abstract][Full Text] [Related]
11. A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A.
Richards M; Williams M; Chalmers E; Liesner R; Collins P; Vidler V; Hanley J;
Br J Haematol; 2010 May; 149(4):498-507. PubMed ID: 20230411
[TBL] [Abstract][Full Text] [Related]
12. Experience with prophylaxis in Sweden.
Nilsson IM
Semin Hematol; 1993 Jul; 30(3 Suppl 2):16-9. PubMed ID: 8367738
[No Abstract] [Full Text] [Related]
13. Articular status of haemophilia patients with inhibitors.
Morfini M
Haemophilia; 2008 Nov; 14 Suppl 6():20-2. PubMed ID: 19134029
[TBL] [Abstract][Full Text] [Related]
14. Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed.
van Dijk K; Fischer K; van der Bom JG; Grobbee DE; van den Berg HM
Haemophilia; 2005 Sep; 11(5):438-43. PubMed ID: 16128885
[TBL] [Abstract][Full Text] [Related]
15. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
Lowe GD
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
[TBL] [Abstract][Full Text] [Related]
16. Neurosurgical intervention in a haemophilic child with a subdural and intracerebral haematoma.
Cermelj M; Negro F; Schijman E; Ferro AM; Acerenza M; Pollola J
Haemophilia; 2004 Jul; 10(4):405-7. PubMed ID: 15230958
[TBL] [Abstract][Full Text] [Related]
17. [Home treatment in hemophilia].
Pabinger I; Niessner H; Korninger C; Nowotny C; Stain M; Kyrle PA; Lechner K
Wien Klin Wochenschr; 1987 Nov; 99(22):773-7. PubMed ID: 3124354
[TBL] [Abstract][Full Text] [Related]
18. Management of carriers and babies with haemophilia.
Street AM; Ljung R; Lavery SA
Haemophilia; 2008 Jul; 14 Suppl 3():181-7. PubMed ID: 18510540
[TBL] [Abstract][Full Text] [Related]
19. The need for previously untreated patient population studies in understanding the development of factor VIII inhibitors.
Gomperts ED
Haemophilia; 2006 Nov; 12(6):573-8. PubMed ID: 17083506
[TBL] [Abstract][Full Text] [Related]
20. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
